200
Views
2
CrossRef citations to date
0
Altmetric
Clinical focus: Cardiometabolic Conditions - Original Research

Sex-disparities in risk factors and atherosclerosis cardiovascular disease in diabetic patients

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 860-864 | Received 10 Feb 2021, Accepted 13 Apr 2021, Published online: 26 Apr 2021

References

  • Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141(9):e139–e596.
  • Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
  • Ma LY, Chen WW, Gao RL, et al. China cardiovascular diseases report 2018: an updated summary. JGC. 2020;17(1):1–8.
  • Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement. J Am Coll Cardiol. 2019;73(24):3135–3147.
  • Hu Y, Zong G, Liu G, et al. Smoking cessation, weight change, type 2 diabetes, and mortality. N Engl J Med. 2018;379(7):623–632.
  • Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–1101.
  • Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: management of Hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD). Diabetes Care. 2020;43(2):487–493.
  • Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–1500.
  • Jenkins DJA, Dehghan M, Mente A, et al. Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med. 2021;384(14):1312–1322.
  • Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347–357.
  • Haider A, Bengs S, Luu J, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41(13):1328–1336.
  • Backholer K, Peters SAE, Bots SH, et al. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71(6):550–557.
  • Mefford MT, Li BH, Qian L, et al. Sex-specific trends in acute myocardial infarction within an integrated healthcare network, 2000 through 2014. Circulation. 2020;141(7):509–519.
  • DeFilippis EM, Collins BL, Singh A, et al. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the mass general Brigham YOUNG-MI registry. Eur Heart J. 2020;41(42):4127–4137.
  • Chichareon P, Modolo R, Kerkmeijer L, et al. Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the GLOBAL LEADERS randomized clinical trial. JAMA Cardiol. 2020;5(1):21-29.
  • Raphael CE, Singh M, Bell M, et al. Sex differences in long-term cause-specific mortality after percutaneous coronary intervention: temporal trends and mechanisms. Circ Cardiovasc Interventions. 2018;11(3):e006062.
  • Mehilli J, Ndrepepa G, Kastrati A, et al. Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from intracoronary stenting and antithrombotic regimen: rapid early action for coronary treatment 2 trial. Am Heart J. 2007;154(1):e151–157.
  • Venetsanos D, Sederholm Lawesson S, Alfredsson J, et al. Association between gender and short-term outcome in patients with ST elevation myocardial infarction participating in the international, prospective, randomised administration of ticagrelor in the catheterisation laboratory or in the ambulance for new st elevation myocardial infarction to open the coronary artery (ATLANTIC) trial: a prespecified analysis. BMJ Open. 2017;7(9):e015241.
  • Bavishi C, Bangalore S, Patel D, et al. Short and long-term mortality in women and men undergoing primary angioplasty: a comprehensive meta-analysis. Int J Cardiol. 2015;198:123–130.
  • Cenko E, Van Der Schaar M, Yoon J, et al. Sex-specific treatment effects after primary percutaneous intervention: a study on coronary blood flow and delay to hospital presentation. J Am Heart Assoc. 2019;8(4):e011190.
  • Garcia M, Mulvagh SL, Merz CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273–1293.
  • Bugiardini R, Yan AT, Yan RT, et al. Factors influencing underutilization of evidence-based therapies in women. Eur Heart J. 2011;32(11):1337–1344.
  • Peters SAE, Colantonio LD, Zhao H, et al. Sex differences in high-intensity statin use following myocardial infarction in the United States. J Am Coll Cardiol. 2018;71(16):1729–1737.
  • [Chinese guidelines for the prevention of cardiovascular diseases (2017)]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46(1):10–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.